Randomized Phase II Trial of Capecitabine and Lapatinib with or without IMC-A12 (Cituxumumab) in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab and Chemotherapy: NCCTG N0733 (Alliance). - Haddad TC; He J; O'Sullivan CC; Chen B; Northfelt D; Dueck AC; Ballman KV; Tenner KS; Linden H; Sparano JA; Hopkins JO; De Silva C; et al. (Breast cancer research and treatment, 2021)